Stem Cells Funding This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (STTR)(R41/R42)
Funding Opportunity Number: PA-13-224 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.28693.35193.859Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2016Award Ceiling: Expected Number of Awards: Creation Date: May 08, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop or improve technologies for obtaining, characterizing and testing animal and human...
Source: Grants.gov - May 11, 2013 Category: Research Tags: Health Source Type: funding

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (SBIR)(R43/R44)
Funding Opportunity Number: PA-13-223 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.28693.35193.859Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2016Award Ceiling: Expected Number of Awards: Creation Date: May 08, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop or improve technologies for obtaining, characterizing and testing animal and human...
Source: Grants.gov - May 11, 2013 Category: Research Tags: Health Source Type: funding

National Cooperative Reprogrammed Cell Research Groups (NCRCRG) to Study Mental Illness (U19)
Funding Opportunity Number: PAR-13-225 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.242Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the I...
Source: Grants.gov - May 11, 2013 Category: Research Tags: Health Source Type: funding

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (SBIR)(R43/R44)
Funding Opportunity PA-13-223 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop or improve technologies for obtaining, characterizing and testing animal and human stem cells and their derivatives as models for stem cell-based regenerative medicine using animal models. The program is intended to support projects devoted to the creation of informative animal models for regenerative medicine, which will facilitate testing the safety and therapeutic potent...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 8, 2013 Category: Research Source Type: funding

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (STTR)(R41/R42)
Funding Opportunity PA-13-224 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop or improve technologies for obtaining, characterizing and testing animal and human stem cells and their derivatives as models for stem cell-based regenerative medicine using animal models. The program is intended to support projects devoted to the creation of informative animal models for regenerative medicine, which will facilitate testing the safety and therapeutic potent...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 8, 2013 Category: Research Source Type: funding

National Cooperative Reprogrammed Cell Research Groups (NCRCRG) to Study Mental Illness (U19)
Funding Opportunity PAR-13-225 from the NIH Guide for Grants and Contracts. The purpose of the National Cooperative Reprogrammed Cell Research Groups (NCRCRG) program is to create multidisciplinary research groups, in partnership with academia and industry, to use patient-derived reprogrammed cells to develop validated platforms for identifying novel targets and developing new therapeutics or diagnostic tools to reduce the burden of mental illness. The collaborations will be pre-competitive, meaning that they lie at the interface between basic academic research and proprietary industrial research and involve cooperation...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 8, 2013 Category: Research Source Type: funding

Call for Research Grant Applications: Cicatricial Alopecia Research Foundation
The Cicatricial Alopecia Research Foundation (CARF) seeks original, focused, and innovative research grant applications dealing with primary cicatricial alopecia (PCA). Applications will be accepted from laboratories around the world. The proposed project must serve to further CARF's research goals, namely, to understand the pathogenesis of PCA, an understanding that will lead to effective prevention and therapy. CARF will give priority to research proposals based on the following topics. Role of lipids and lipid metabolism in normal hair follicle stem cell biology and cycling Role of PPARs and other lipid regul...
Source: ScanGrants feed - May 7, 2013 Category: Research Authors: Cicatricial Alopecia Research Foundation Source Type: funding

ISCTR-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship
sponsored by Dignity Health, St. John's Hospital The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research. One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and dev...
Source: ScanGrants feed - May 6, 2013 Category: Research Authors: International Society for Cardiovascular Translational Research/American College of Cardiology Foundation Source Type: funding

Doctors Cancer Foundation Grant Program
There will be a $50,000 grant in 2013 for the best program for the management of cancer. There may be an additional $50,000 Nolan Miller grant for the best program for lung cancer. There is a strong interest in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others. We are particularly interested in promoting the best of the young scientists, currently under the radar screen. We are NOT looking at studies that show that drug A is 3% better than drug B. The project should be innovative, sound and be able to lead to clnical trials. All such projects will get equal consideration. Research gran...
Source: ScanGrants feed - April 4, 2013 Category: Research Authors: Doctors Cancer Foundation Source Type: funding

Notice of NIAMS' Participation in PAR-13-115 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)
Notice NOT-AR-13-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2013 Category: Research Source Type: funding

Notice of NIAMS' Participation in PAR-13-114 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
Notice NOT-AR-13-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2013 Category: Research Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)
Funding Opportunity Number: PAR-13-115 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.12193.35193.837Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, ...
Source: Grants.gov - February 11, 2013 Category: Research Tags: Health Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
Funding Opportunity Number: PAR-13-113 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.351Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than i...
Source: Grants.gov - February 11, 2013 Category: Research Tags: Health Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
Funding Opportunity Number: PAR-13-114 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.12193.35193.83793.84793.859Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 5...
Source: Grants.gov - February 11, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)
Funding Opportunity PAR-13-115 from the NIH Guide for Grants and Contracts. This FOA encourages Exploratory/Developmental Research grant (R21) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 11, 2013 Category: Research Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
Funding Opportunity PAR-13-114 from the NIH Guide for Grants and Contracts. This FOA encourages Research Project Grant (R01) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2)...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 11, 2013 Category: Research Source Type: funding

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
Funding Opportunity PAR-13-113 from the NIH Guide for Grants and Contracts. This FOA encourages Resource-Related Research Project Grant (R24) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing and creating new animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative mo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 11, 2013 Category: Research Source Type: funding

Request for Applications for Basic, Clinical, and Translational Research on Stem Cells for Lupus
Award Amount: $120,000 Letter of Intent Deadline: February 22, 2013 at 5 p.m. ET In recent years, research on stem cells for lupus has been of increased interest. In particular, in the past decade, autologous, hematopoietic, and mesenchymal stem cell transplantation have been reported as a promising therapy to achieve treatment-free, long-term remission in people with lupus. However, this research is still in its infancy and further work is needed to clarify issues relevant to relapse, treatment-related toxicity, and the development of secondary autoimmune disorders in recipients of stem cells as a treatment for lup...
Source: ScanGrants feed - January 30, 2013 Category: Research Authors: Lupus Foundation of America Source Type: funding

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R01)
Funding Opportunity Number: PAR-13-094 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCFDA Number: 93.865Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3...
Source: Grants.gov - January 29, 2013 Category: Research Tags: Health Income Security and Social Services Source Type: funding

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R21)
Funding Opportunity Number: PAR-13-095 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCFDA Number: 93.865Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3...
Source: Grants.gov - January 29, 2013 Category: Research Tags: Health Income Security and Social Services Source Type: funding

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R21)
Funding Opportunity PAR-13-095 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is intended to encourage innovative and high risk/impact research in the area of stem cell biology, to be explored in model organisms. The research proposed under this program can explore approaches and concepts new to this area; development of new technologies; or initial research and development of data upon which significant future research may be built. The primary focus of the FOA is to promote in...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 28, 2013 Category: Research Source Type: funding

Differentiation and Integration of Stem Cells (Embryonic and Induced-Pluripotent) Into Developing or Damaged Tissues (R01)
Funding Opportunity PAR-13-094 from the NIH Guide for Grants and Contracts. The primary focus of the FOA is to promote in vivo studies of stem cells in animal models and in humans (if applicable) to better understand how stem cells function within developing or damaged tissues. The areas of emphasis would include systematically profiling and cataloging changes at genetic and epigenetic levels that take place in stem cells and their microenvironment. The purpose is to gain in-depth knowledge of the mechanisms involved in: progressive differentiation of Embryonic Stem Cells (ESCs) into embryonic lineages, progenitor cells...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 28, 2013 Category: Research Source Type: funding

Call for Applications: Career Development Awards in Support of Research into Inherited Orphan Retinal Degenerative Diseases and Non-Exudative Age-Related Macular Degeneration
Application Deadline: March 15, 2013 The Foundation Fighting Blindness (FFB) is soliciting applications for Career Development Awards (CDA) from clinical research scientists of superior dedication and talent. The award is for junior investigators to pursue vigorous research programs to drive the research to find the therapies and cures for retinal degenerative diseases (RDDs), i.e., inherited orphan retinal degenerative diseases and non-exudative age-related macular degeneration. The goal of this Program is to facilitate advances in laboratory and clinical research, to elucidate the mechanisms for the etiology and pat...
Source: ScanGrants feed - January 28, 2013 Category: Research Authors: Foundation Fighting Blindness Source Type: funding

National Tay-Sachs & Allied Diseases Association Request for Proposals
National Tay-Sachs & Allied Diseases Association Request for Proposals The National Tay-Sachs & Allied Diseases Association Inc. (NTSAD) is considered to be the nation’s oldest genetic disease nonprofit organization. The “Allied Diseases” represent a family of almost 100 rare diseases including lysosomal storage diseases (LSD) and leukodystrophies affecting the central nervous system. A major element of NTSAD’s mission is to lead the fight to treat and cure Tay-Sachs, Canavan and related genetic diseases; therefore, NTSAD is committed to funding research projects that advance this mission....
Source: ScanGrants feed - January 3, 2013 Category: Research Authors: National Tay-Sachs & Allied Diseases Association Source Type: funding

Senior Scholar in Aging Award
The Ellison Medical Foundation Senior Scholar program is designed to support established investigators working at institutions in the U.S. to conduct research in the basic biological and basic biomedical sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide significant support to allow the development of new, creative research programs by investigators who may not currently be conducting aging research or who wish to develop new research programs in aging. The Foundation particularly seeks to stimulate new research that has rigorous ...
Source: ScanGrants feed - December 30, 2012 Category: Research Authors: Ellison Medical Foundation Source Type: funding

Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01)
Funding Opportunity Number: PAR-13-066 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the...
Source: Grants.gov - December 21, 2012 Category: Research Tags: Food and Nutrition Health Source Type: funding

Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01)
Funding Opportunity PAR-13-066 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R01) applications to conduct ancillary studies to the NIDDK Intestinal Stem Cell Consortium (ISCC). Studies will make use of consortium collaborations, techniques or resources to accelerate research into intestinal stem cells. The proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest to the Institute and commensurate with the interests and intent of the ISCC. (Source: NIH Funding...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2012 Category: Research Source Type: funding

Stanford Summer Research Program/Amgen Scholars Program
Applications are due February 1, 2013. The Stanford Summer Research Program/Amgen Scholars Program is a fully funded, nine week, residential research program. It offers undergraduates who want to prepare for and enter Ph.D. programs in the sciences a unique opportunity for advanced research experience within a world class university. Our program dates for 2013 are June 22 - August 24 The SSRP-Amgen Scholars Program is a research-intensive residential program that takes place on Stanford's beautiful campus for a nine-week period. Participant are matched with a member of Stanford’s distinguished faculty an...
Source: ScanGrants feed - December 12, 2012 Category: Research Authors: Stanford University/Amgen Source Type: funding

World Anti-Doping Agency Research Grant Program
The 2013 deadline to submit research applications is February 17. The World Anti-Doping Agency (WADA) promotes, coordinates and monitors, at the international level, the fight against doping in all its forms. Through this independent agency, the Olympic Movement and the Public Authorities have intensified their efforts to keep drugs out of sport. 2013 Scientific Research Topics The World Anti-Doping Agency’s (WADA) Health, Medical and Research Committee (HMRC) has identified relevant areas of research in the field of anti-doping, in particular those related to the List of Prohibited Substances and Methods in...
Source: ScanGrants feed - December 9, 2012 Category: Research Authors: World Anti-Doping Agency Source Type: funding

JDRF Requests Letters of Intent: Biologic Factors and Targets for Promoting Beta Cell Regeneration, Health, and Survival
Letter of Intent Deadline: December 3, 2012 JDRF invites applications from single investigators or teams of investigators to develop and conduct studies towards the goal of discovering and validating druggable targets and biologic factors for promoting pancreatic beta cell regeneration, health and survival in type 1 diabetes. Type I diabetes (T1D) is characterized by the declining function and loss of the insulin-producing beta cells of the islet resulting in a need for life-long insulin replacement therapy. Therapies to safely restore functional beta cell mass and maintain or prevent loss of beta cell function are ...
Source: ScanGrants feed - November 28, 2012 Category: Research Authors: JDRF Source Type: funding

Call for Young Investigator and Underrepresented Minority Travel Fellowship and Child-Care Grant Applications for The Bone Marrow Niche, Stem Cells, and Leukemia
: Impact of Drugs, Chemicals, and the Environment May 29 - 31, 2013 The New York Academy of Sciences Presented by Rutgers, The State University of New Jersey and the New York Academy of Sciences Over 20,000 Americans are diagnosed each year with bone marrow failure syndromes. Environmental, chemical, and genetic factors have been linked to the development of lymphomas, leukemias, and myelodysplastic syndromes (MDS). Additionally, some anti-cancer drugs have been shown to themselves induce DNA damage and secondary cancers. In light of increasing societal exposure to toxic environmental agents that may be carcinogenic,...
Source: ScanGrants feed - November 12, 2012 Category: Research Authors: New York Academy of Sciences Source Type: funding

Request for Applications: Cooley’s Anemia Foundation Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award
Request for Applications: Cooley’s Anemia Foundation Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award The Cooley’s Anemia Foundation invites national and international applicants to apply for grants to facilitate clinical trials in Cell and Gene Therapy to advance a cure for thalassemia. The purpose of this initiative is to speed the application of recent translational advances in cell and gene therapy to clinical trials. Both phase I (safety) and phase II (efficacy) trials are eligible for support. Funding and candidate eligibility Applicants should state explicitly the status of their pr...
Source: ScanGrants feed - October 30, 2012 Category: Research Authors: Cooley’s Anemia Foundation Source Type: funding

Call for Applications: Cooley’s Anemia Foundation Research Fellowships
Call for Applications: Cooley’s Anemia Foundation Research Fellowships The Cooley’s Anemia Foundation invites national and international clinical and basic science investigators (postdoctoral or junior faculty) to apply for its prestigious fellowship program. Applications should be focused on the understanding or treatment of thalassemia or a complication that is related to thalassemia. The areas of interest include, but are not limited to, studies of globin gene regulation, globin gene transfer and expression, fetal hemoglobin production, hematopoietic stem cell research, bone marrow transplantation, i...
Source: ScanGrants feed - October 30, 2012 Category: Research Authors: Cooley’s Anemia Foundation Source Type: funding

Request for Proposals: Neurofibromatosis Therapeutic Acceleration Program
Proposal Submission Deadline: November 9, 2012 at 12:00p (noon) The Neurofibromatosis Therapeutic Acceleration Program (NTAP) invites proposals for the development of novel cell culture model systems for Neurofibromatosis Type 1 (NF1) plexiform neurofibromas. Limited availability of cellular models of human plexiform neurofibromas is a major hurdle to rapidly developing therapies for these tumors. To address this barrier, NTAP is collaborating with technology experts and supporting investigators to develop, characterize and validate cellular model systems for NF1 associated plexiform neurofibromas. Successful prop...
Source: ScanGrants feed - October 23, 2012 Category: Research Authors: Request for Proposals: Neurofibromatosis Therapeutic Acceleration Program Source Type: funding

Call for Applications: 2013 American Federation for Aging Research Research Grant
AFAR provides up to $100,000 for a one- to two-year award to junior faculty (M.D.s and Ph.D.s) to conduct research that will serve as the basis for longer term research efforts. AFAR-supported investigators study a broad range of biomedical and clinical topics including the causes of cellular senescence, the role of estrogen in the development of osteoporosis, the genetic factors associated with Alzheimer's disease, the effects of nutrition and exercise on the aging process, and much more. Since 1981, over 680 AFAR Research Grants have been awarded. Up to 10 awards will be given in 2013. Application Deadline: Dece...
Source: ScanGrants feed - October 22, 2012 Category: Research Authors: American Federation for Aging Research Source Type: funding

Call for Appplications: Glenn/American Federation for Aging Research Scholarships for Research in the Biology of Aging
The Glenn/AFAR Scholarships for Research in the Biology of Aging have been established in order to continue to attract new generations of talented investigators to the field of aging research. The program is designed to give students enrolled in MD, DO, PhD, or combined-degree programs the opportunity to conduct a three-to-six month research project focused on biomedical research in aging. Up to ten $5,000 scholarships will be awarded in 2013. Application Deadline: January 15, 2013. It is a well-known fact that America’s population is aging dramatically – it is estimated that 20% of the population will b...
Source: ScanGrants feed - October 22, 2012 Category: Research Authors: American Federation for Aging Research Source Type: funding

KY Cha Award in Stem Cell Technology
This report should be signed by the recipient of the award and the Chair of the Department. At the conclusion of the project, a manuscript should be submitted for review by the Editorial Board for publication in Fertility and Sterility, the Journal of Assisted Reproduction and Genetics or another peer reviewed journal if more appropriate. Any published report must carry the acknowledgment “Supported by the KY Cha Award in Stem Cell Technology.” If data are presented at a national or international scientific meeting, they should be presented at the ASRM Annual Meeting. If the applicant has other funding for the ...
Source: ScanGrants feed - October 1, 2012 Category: Research Authors: American Society for Reproductive Medicine Source Type: funding

Request for Applications: Alliance for Cancer Gene Therapy 2012 Young Investigator Award
Abstract Deadline: September 4, 2012 at 4pm E.S.T. Invitation to Submit Application: September 19, 2012 Deadline for Completed Application: October 19, 2012 at 4 pm E.S.T. The Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. To this end, ACGT offers its Young Investigator Award to qualified scientists at the Tenure Track Assistant Professor level. ELIGIBILITY REQUIREMENTS Candidates for a Young Investigator Award must hold an MD, MPH, PhD, or equivalent degree, and be a TENURE TRACK Assistant Profes...
Source: ScanGrants feed - August 29, 2012 Category: Research Authors: Alliance for Cancer Gene Therapy Source Type: funding

Orthopaedic Research and Education Foundation/Musculoskeletal Transplant Foundation Research Grant
Applications due September 14, 2012 This grant provides start-up funding or seed money for a new investigator researching the science of biologic skeletal reconstruction, including implants and stem cells. Thanks to generous support from the Musculoskeletal Transplant Foundation, one grant totaling up to $100,000 for a maximum time period of two years is available, conditional upon annual review. Clinical relevance must be clearly noted in the abstract and specific aims, and be explicit in both the project title and the study design. The principal or co-principal investigator must be an orthopaedic surgeon. PhDs and D...
Source: ScanGrants feed - July 30, 2012 Category: Research Authors: Orthopaedic Research and Education Foundation/Musculoskeletal Transplant Foundation Source Type: funding

Call for Applications: Translational Research Training in Hematology
Discussions will focus on ethical and regulatory issues in Europe and North America related to translational research. Topics will include good clinical practice (GCP), quality care assurance, good manufacturing practice (GMP), relationships with the pharmaceutical and biotech industry, and intellectual property. Career development insight Career retrospectives are provided from leading hematologists with a broad experience in translational research. Hematology pioneers will speak about their personal and career challenges and successes, and maintaining a work-life balance. Small-group working sessions Small workin...
Source: ScanGrants feed - June 20, 2012 Category: Research Authors: European Hematology Association/American Society of Hematology Source Type: funding

Center for Genomic Studies on Mental Disorders (U24)
Funding Opportunity Number: RFA-MH-13-050 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.242Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with th...
Source: Grants.gov - May 30, 2012 Category: Research Tags: Health Source Type: funding

Center for Genomic Studies on Mental Disorders (U24)
Funding Opportunity RFA-MH-13-050 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Institute of Mental Health (NIMH) seeks Resource-Related Cooperative Agreement (U24) applications to continue, enhance, and enrich research resources in the NIMH Human Genetics Initiative for free and open sharing with the scientific community. The long-term objective of data sharing and research resource enrichment under this FOA is to accelerate gene discovery in mental disorders. It is expected that the Center will be comprised of a team of investigators with expertise in mo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 30, 2012 Category: Research Source Type: funding

3CPR Max Harry Weil Award
Sponsored by the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) Application deadline: June 29, 2012 The 3CPR Max Harry Weil Award was established in 2012. The award acknowledges the accomplishments of young investigators and to encourage investigators to continue their research in biomedical sciences relevant to the mission and scope of the 3CPR council. This award honors the memory of Max Harry Weil, MD, PhD, considered the “father of critical care medicine” and a pioneer in 3CPR science. Finalists will be honored and a winner will be named at the annual council di...
Source: ScanGrants feed - May 21, 2012 Category: Research Authors: Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) Source Type: funding

2012 American Society for Cell Biology Annual Meeting Minorities Affairs Committee Travel Award
Application Deadline: September 4, 2012 2012 American Society for Cell Biology Annual Meeting December 15-19, 2012 San Francisco, California Applicants may apply for a Minorities Travel Award (up to $1,800 towards meeting expenses). Meeting expenses can include lodging, travel, meals, ground transportation, poster presentation expenses, and meeting registration. ASCB MAC Travel Award Recipients are required to attend the MAC Mentoring Symposium and Poster Session on Saturday, December 15, 2012 and to assist MAC members in the MAC/EdComm Information Booth at an agreed upon period during the meeting. The MAC Saturday ...
Source: ScanGrants feed - May 14, 2012 Category: Research Authors: American Society for Cell Biology Source Type: funding

Travel Grants to 2012 Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology
October 31 - November 3, 2012 Miami, Florida The 2012 Annual Meeting of the American Pancreatic Association (APA) to be held jointly with the International Association of Pancreatology (IAP) will take place at the Eden Roc Renaissance in Miami Beach FL from Oct 31-Nov 3. The meeting will include several mini-symposia in addition to abstract driven sessions including a symposia on Pancreatic Stem Cells and Stellate Cells (organized by Minoti Apte and Diane Simeone on Saturday Nov 3) and a consensus conference open to all participants to update the 2002 IAP Evidence-Based Guidelines on the Management of Acute Pancreati...
Source: ScanGrants feed - May 10, 2012 Category: Research Authors: American Pancreatic Association/International Association of Pancreatology Source Type: funding

International Society for Cardiovascular Translational Research-American College of Cardiology Foundation Cardiovascular Translational Research Scholarship
The purpose of the program is to recognize and provide financial support for research efforts by outstanding cardiovascular scholars. This scholarship is to encourage junior faculty in the early phases of their careers in the field of cardiology. The program is intended for a physician with a strong interest in developing a career in cardiovascular translational research. One year of previous interventional cardiology training is required. The duration of the program is one year. The awardee will develop skills and expertise in translating basic biological and device concepts into clinical application. NOTE: this progra...
Source: ScanGrants feed - May 7, 2012 Category: Research Authors: International Society for Cardiovascular Translational Research/American College of Cardiology Foundation Source Type: funding

Grants & Postdoctoral Fellowships for Studies Aimed at Fragile X Treatment
Grants & Postdoctoral Fellowships for Studies Aimed at Fragile X Treatment Please send a letter of intent prior to application (by Jan 20, 2013, at the latest), since only those applications which meet the highest standards of translational relevance will be reviewed. FRAXA's grants and fellowships program aims to encourage research aimed at finding a specific treatment for fragile X syndrome. FRAXA's goal is to bring practical treatment into current medical practice as quickly as possible; therefore, preference will be given to research projects that have a clear practical application and the results of wh...
Source: ScanGrants feed - April 3, 2012 Category: Research Authors: FRAXA Source Type: funding

Laennec Young Clinician Award
Sponsored by the Council on Clinical Cardiology Application Deadline: June 8, 2012 The Laennec Young Clinician Award recognizes the importance of clinical acumen, inductive analytic skills, and teaching ability in future academic cardiologists. Current fellows in training who are members of the council are eligible to apply. Eligibility Criteria Candidate must be enrolled as a fellow in a U.S. clinical cardiovascular fellowship training program at the time of presentation (through November 2012) All applicants for Early Career Investigator Awards sponsored by a scientific council must be members of the AHA/ASA...
Source: ScanGrants feed - March 20, 2012 Category: Research Authors: Council on Clinical Cardiology Source Type: funding

R&D Systems Travel Grants to Attend the International Society for Stem Research 10th Annual Meeting (ISSCR 2012)
R&D Systems Travel Grants to Attend the International Society for Stem Research 10th Annual Meeting (ISSCR 2012) To apply for one of ten $1,000 travel grants to attend the International Society for Stem Cell Research 10th Annual Meeting in Yokohama, Japan (June 13-16, 2012), simply fill out the online application form. Step 1: Fill in your contact details. Step 2: Submit your abstract/travel justification. Winners will be determined by the novelty and significance of the scientific research described. The application submission deadline is April 30th, 2012. Winners will be announced May 31st, 2012. (Source: ScanGrants feed)
Source: ScanGrants feed - March 8, 2012 Category: Research Authors: R&D Systems Source Type: funding

Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01)
Funding Opportunity Number: RFA-EY-12-001 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.867Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other tha...
Source: Grants.gov - February 9, 2012 Category: Research Tags: Health Source Type: funding